Literature DB >> 31620863

Vitamin D rise enhances blood perfusion in patients with multiple sclerosis.

Thomas Müller1, Lutz Lohse2, Andreas Blodau3, Katja Frommholz4.   

Abstract

The chemical structure of vitamin D resembles steroids and anabolics. Following activation by enzymatic hydroxylation, vitamin D enhances numerous body functions. We determined 25-hydroxy-vitamin D, number of erythrocytes, haematocrit, mean corpuscular haemoglobin and mean corpuscular volume in 97 patients with multiple sclerosis initially and 6 months later. Patients with deficient levels of 25-hydroxyvitamin D (< 30 ng/mL) were advised to perform vitamin D supplementation and received a prescription of a vitamin D formulation. Six months later we observed a rise of 25-OH-vitamin D, as to be expected, and a modified constellation of blood parameters such as elevation of mean corpuscular haemoglobin concentration and fall of mean corpuscular volume. Mean corpuscular haemoglobin and number of erythrocytes remained stable. The haematocrit went down. We suggest that vitamin D elevation may be beneficial in disorders characterised by chronic neuroinflammation and neurodegeneration, since changes of blood perfusion parameters may enhance cellular tissue oxygenation.

Entities:  

Keywords:  Blood; Haematocrit; Haemoglobin; Vitamin D

Year:  2019        PMID: 31620863     DOI: 10.1007/s00702-019-02093-x

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  18 in total

1.  Vitamin D: A novel protective factor for delirium?

Authors:  Susanna C Larsson; Leon Flicker
Journal:  Neurology       Date:  2019-02-15       Impact factor: 9.910

2.  State- and trait-dependent associations of vitamin-D with brain function during aging.

Authors:  Alexandra M Kueider; Toshiko Tanaka; Yang An; Melissa H Kitner-Triolo; Elango Palchamy; Luigi Ferrucci; Madhav Thambisetty
Journal:  Neurobiol Aging       Date:  2015-11-18       Impact factor: 4.673

Review 3.  Vitamin D and remyelination in multiple sclerosis.

Authors:  J Matías-Guíu; C Oreja-Guevara; J A Matias-Guiu; U Gomez-Pinedo
Journal:  Neurologia (Engl Ed)       Date:  2016-06-16

4.  Immune regulatory effects of high dose vitamin D3 supplementation in a randomized controlled trial in relapsing remitting multiple sclerosis patients receiving IFNβ; the SOLARIUM study.

Authors:  Anne-Hilde Muris; Joost Smolders; Linda Rolf; Marielle Thewissen; Raymond Hupperts; Jan Damoiseaux
Journal:  J Neuroimmunol       Date:  2016-10-03       Impact factor: 3.478

5.  Vitamin D-Rich Diet in Mice Modulates Erythrocyte Survival.

Authors:  Elisabeth Lang; Kashif Jilani; Rosi Bissinger; Rexhep Rexhepaj; Christine Zelenak; Adrian Lupescu; Florian Lang; Syed M Qadri
Journal:  Kidney Blood Press Res       Date:  2015-07-27       Impact factor: 2.687

6.  Association of seasonal serum 25-hydroxyvitamin D levels with disability and relapses in relapsing-remitting multiple sclerosis.

Authors:  W Brola; P Sobolewski; W Szczuchniak; A Góral; M Fudala; W Przybylski; J Opara
Journal:  Eur J Clin Nutr       Date:  2016-03-30       Impact factor: 4.016

7.  Levodopa increases oxidative stress and repulsive guidance molecule A levels: a pilot study in patients with Parkinson's disease.

Authors:  Thomas Müller; Isabel Trommer; Siegfried Muhlack; Bernhard K Mueller
Journal:  J Neural Transm (Vienna)       Date:  2016-02-15       Impact factor: 3.575

8.  Oxidative Stress Related to Iron Metabolism in Relapsing Remitting Multiple Sclerosis Patients With Low Disability.

Authors:  Mariacristina Siotto; Maria Maddalena Filippi; Ilaria Simonelli; Doriana Landi; Anna Ghazaryan; Stefano Vollaro; Mariacarla Ventriglia; Patrizio Pasqualetti; Mauro Ciro Antonio Rongioletti; Rosanna Squitti; Fabrizio Vernieri
Journal:  Front Neurosci       Date:  2019-02-11       Impact factor: 4.677

Review 9.  Vitamin D and neurocognitive function.

Authors:  Mathias Schlögl; Michael F Holick
Journal:  Clin Interv Aging       Date:  2014-04-02       Impact factor: 4.458

10.  Inhibiting repulsive guidance molecule-a suppresses secondary progression in mouse models of multiple sclerosis.

Authors:  Shogo Tanabe; Yuki Fujita; Kaori Ikuma; Toshihide Yamashita
Journal:  Cell Death Dis       Date:  2018-10-17       Impact factor: 8.469

View more
  2 in total

Review 1.  Physiological and Pathological Functions of Neuronal Hemoglobin: A Key Underappreciated Protein in Parkinson's Disease.

Authors:  Ran Zheng; Yiqun Yan; Jiali Pu; Baorong Zhang
Journal:  Int J Mol Sci       Date:  2022-08-13       Impact factor: 6.208

2.  No Vitamin D Deficiency in Patients with Parkinson's Disease.

Authors:  Wilfried Kuhn; Georg Karp; Thomas Müller
Journal:  Degener Neurol Neuromuscul Dis       Date:  2022-09-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.